Alimera Sciences Inc (ALIM) - News Archive

In recent news, Alimera Sciences Inc, a prominent player in the healthcare sector, has experienced a series of significant events that have impacted its financial outlook. These events include a downgrade by HC Wainwrig...

Alimera Sciences Reports Inducement Grants: Assessing Impact on Company SharesAlimera Sciences, a global pharmaceutical company focused on retinal health, recently announced the approval of inducement awards for five no...

Alimera Sciences Announces Inducement Grants: What Does This Mean for the Company s Shares?Alimera Sciences, a leading global pharmaceutical company specializing in retinal health and improving vision, recently made an...

Radiation retinopathy is a severe side effect of radiation therapy, causing visual acuity loss and potentially leading to blindness. The groundbreaking research study conducted by the DRCR Retina Network, in partnership...

Alimera Sciences, a renowned pharmaceutical company specializing in ophthalmic solutions, recently announced the completion of patient recruitment for their groundbreaking Synchronicity Study. This significant milestone...

Alimera Sciences, a prominent global pharmaceutical company focused on retinal health, recently announced the appointment of Todd Wood as the President of U.S. operations. This strategic move comes as the company strive...